Ireland· IE-PA-EU/1/22/1670/003-004
Scemblix 40 mg film-coated tablets
A asciminib product containing asciminib hydrochloride, registered in Ireland by Novartis Europharm Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Asciminib is registered in 16 of 19 countries.
Countries holding a registration under ATC L01EA06 (asciminib), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Asciminib · ATC L01EA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of asciminib costs, country by country.
Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.27 in France to $162.23 in Switzerland — a ×606 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Asciminib · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- CH Switzerland$162.23
- FR France$0.27
The record
At a glance
HPRA (Ireland)- Active substance
- Asciminib hydrochloride
- Manufacturer
- Novartis Europharm Limited
- Country
- Ireland (IE)
- ATC code
- L01EA06
- ATC class
- Asciminib
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/22/1670/003-004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Asciminib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSCEMBLIXNovartis Europharm Limited, Dublin
- SwitzerlandScemblix 40 mg, FilmtablettenNovartis Pharma Schweiz AG
- SpainSCEMBLIX 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- FinlandScemblixNovartis Europharm Limited
- FranceSCEMBLIX 40 mg, comprimés pelliculésNOVARTIS EUROPHARM (IRLANDE)
- IcelandScemblixNovartis Europharm Limited*
- NetherlandsScemblix 40mg, filmomhulde tabletNovartis Europharm Limited
- NorwayScemblixNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scemblix
- Liechtenstein · Scemblix
- Norway · Scemblix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3338cdca-0c09-4e26-90b6-32d41d9b22f2 GET /v1/drugs/3338cdca-0c09-4e26-90b6-32d41d9b22f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01EA06"
],
"strength": null,
"pa_number": "EU/1/22/1670/003-004",
"substances": [
"Asciminib hydrochloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "25/08/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about asciminib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.